A universal programmer for implantable cardioverter defibrillators (ICDs) and pacemakers, the Merlin Patient Care System is designed to help physicians conduct tests, analyze therapeutic and diagnostic data and program implanted devices.
Offering protocol-based workflow tools, The Aquarius Workstation version 3.5 simplifies the interpretation process by ...
The Aplio CV all-digital ultrasound system is intended for advanced cardiovascular applications, allowing for ...
Providing exceptional cardiovascular care for patients to achieve the best possible outcomes is the number one goal for ...
The Elecsys proBNP assay is the first and only natriuretic peptide test to receive FDA clearance for the risk assessment of cardiac events in people who have stable coronary artery disease — nearly 13 million in the U.S.
The Aquilion 64 CFX features advanced multidetector CT imaging technology and is currently being validated in the ...
According to independent clinical studies, the RADPAD Interventional Specialty Shield provides 80 percent radiation ...
Cardiac positron emission tomography (PET) is growing in popularity among cardiologists because it provides the ability ...
Siemens has introduced a 40-slice configuration to its Biograph family of PET/CT systems. The Biograph family — which ...
A computer-based simulator for helping users acquire, develop, maintain and assess the motor skills and cognitive ...
For the first time in the electrophysiological (EP) industry, a heart arrhythmia patient in Italy was treated remotely ...
When performing radiofrequency (RF) ablation to treat cardiac arrhythmia, medical professionals must balance the safety ...
With improved clinical capabilities for cardiac mapping and navigation during EP procedures, EnSite System Version 6 is designed to provide 3-D cardiac models at the time of an EP procedure.
The Ascent 4.7 operating system for the Altaire High-Field Performance Open MRI provides vascular imaging features ...
The FDA has approved revised labeling for the instructions for use of the CYPHER Sirolimus-eluting Coronary Stent. The labeling now reflects FDA's review of clinical trial data that suggests there is no increased risk of myocardial infarction with the use of overlapping CYPHER Stents in comparison to bare metal stents.
Change Healthcare Cardiology Hemodynamics is an integrated hemodynamic monitoring system for monitoring vital signs and ...
Impella Recover technology, which includes the Recover LP 2.5, LD, LP 5.0 and the RD, are commercially available in ...
SceptreP3 is a hybrid PET/CT system that integrates the “Power of Three” suite of differentiating capabilities ...
The ZIPwire Hydrophilic Guide Wire features a number of elements designed to enhance the ability to steer, handle and ...